Prix Galien Greece is the country’s preeminent prize acknowledging the leading-edge of scientific advances in life sciences since 2013
Prix Galien Greece recognize and reward excellence in pharmaceutical achievements that lead to upgrading the quality or, even saving lives through the development of innovative drugs and diagnostics tools.
With a focus on research into natural biomolecules, an increasing number of companies are pioneering the development and clinical validation of specifically designed Nutraceuticals, supported by clinical studies.
These products contribute both to patient stabilization, helping to protect against chronic and autoimmune diseases, and to the management of associated symptoms, ultimately contributing to an improved quality of life.
Products submitted for consideration for the Prix Galien Greece Awards must have received an EOF (National Organization for Medicines) notification number at least five years prior to the application submission deadline.
The judging committee is taking into consideration the following facts:
01/12/2026
01/10/2027
Entries for the 2027 Prix Galien Greece close on 21/05/2027.
We can help! Contact us for more information.
